OBJECTIVE: The role of miR-365 in cancer cells seemed controversial in previous studies. We thereby in this article aimed to define the role of miR-365 in malignant melanoma (MM) pathogenesis. METHODS: We detected miR-365 expression in malignant melanoma cell lines and then investigated the effects of miR-365 on the metastasis and malignancy of melanoma cells. The correlation between miR-365 level and NRP1 (neuropilin1) was further investigated in clinical malignant melanoma specimens. RESULTS: MiR-365 was strongly down-regulated in malignant melanoma (MM) tissues and cell lines, and its expression levels were associated with lymph node metastasis and clinical stage, as well as overall survival and replase-free survival of MM. We also found that ectopic expression of miR-365 inhibited MM cell proliferation and MM metastasis in vitro and in vivo. We further identified a novel mechanism of miR-365 to suppress MM growth and metastasis. NRP1 was proved to be a direct target of miR-365, using luciferase assay and western blot. NRP1 over-expression in miR-365 expressing cells could rescue invasion and growth defects of miR-365. In addition, miR-365 expression inversely correlated with NRP1 protein levels in MM. CONCLUSION: Our data suggest that miR-365 functions as a tumor suppressor in MM development and progression, and holds promise as a prognostic biomarker and potential therapeutic target for MM.
OBJECTIVE: The role of miR-365 in cancer cells seemed controversial in previous studies. We thereby in this article aimed to define the role of miR-365 in malignant melanoma (MM) pathogenesis. METHODS: We detected miR-365 expression in malignant melanoma cell lines and then investigated the effects of miR-365 on the metastasis and malignancy of melanoma cells. The correlation between miR-365 level and NRP1 (neuropilin1) was further investigated in clinical malignant melanoma specimens. RESULTS:MiR-365 was strongly down-regulated in malignant melanoma (MM) tissues and cell lines, and its expression levels were associated with lymph node metastasis and clinical stage, as well as overall survival and replase-free survival of MM. We also found that ectopic expression of miR-365 inhibited MM cell proliferation and MM metastasis in vitro and in vivo. We further identified a novel mechanism of miR-365 to suppress MM growth and metastasis. NRP1 was proved to be a direct target of miR-365, using luciferase assay and western blot. NRP1 over-expression in miR-365 expressing cells could rescue invasion and growth defects of miR-365. In addition, miR-365 expression inversely correlated with NRP1 protein levels in MM. CONCLUSION: Our data suggest that miR-365 functions as a tumor suppressor in MM development and progression, and holds promise as a prognostic biomarker and potential therapeutic target for MM.
Entities:
Keywords:
Malignant melanoma (MM); cancer biomarker; invasion and metastasis; miR-365; neuropilin1 (NRP1); pathogenesis; target therapy
Authors: Susan Achberger; Wayne Aldrich; Raymond Tubbs; John W Crabb; Arun D Singh; Pierre L Triozzi Journal: Mol Immunol Date: 2013-12-25 Impact factor: 4.407
Authors: Sascha Venturelli; Tobias W Sinnberg; Alexander Berger; Seema Noor; Mitchell Paul Levesque; Alexander Böcker; Heike Niessner; Ulrich M Lauer; Michael Bitzer; Claus Garbe; Christian Busch Journal: Front Oncol Date: 2014-08-25 Impact factor: 6.244
Authors: Luigi Fattore; Rita Mancini; Mario Acunzo; Giulia Romano; Alessandro Laganà; Maria Elena Pisanu; Debora Malpicci; Gabriele Madonna; Domenico Mallardo; Marilena Capone; Franco Fulciniti; Luca Mazzucchelli; Gerardo Botti; Carlo M Croce; Paolo Antonio Ascierto; Gennaro Ciliberto Journal: Proc Natl Acad Sci U S A Date: 2016-08-08 Impact factor: 11.205
Authors: Lucas Da Silva; Carlos E Fonseca-Alves; Jennifer J Thompson; Robert A Foster; Geoffrey A Wood; Renee L Amorim; Brenda L Coomber Journal: Vet Med Sci Date: 2017-06-30